CEDAZURIDINE AND DECITABINE

979 reported adverse events

Drug classes: Nucleoside Metabolic Inhibitor [EPC]

These side effects are most commonly reported by patients taking CEDAZURIDINE AND DECITABINE:

# Side effect Count
0 FATIGUE 144
1 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 142
2 CYTOPENIA 129
3 PRODUCT USE IN UNAPPROVED INDICATION 120
4 PLATELET COUNT DECREASED 115
5 DEATH 114
6 WHITE BLOOD CELL COUNT DECREASED 92
7 OFF LABEL USE 78
8 NAUSEA 73
9 TRANSFUSION 71
See all common reactions for CEDAZURIDINE AND DECITABINE

CEDAZURIDINE AND DECITABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERPLASTIC CHOLECYSTOPATHY 4 0.0296
1 RED BLOOD CELL TRANSFUSION 8 0.0195
2 BIOPSY BONE MARROW 7 0.0150
3 PLATELET TRANSFUSION 18 0.0140
4 BLOOD PRODUCT TRANSFUSION DEPENDENT 5 0.0119
5 CYTOPENIA 129 0.0105
6 TRANSFUSION 71 0.0068
7 CHOROIDAL EFFUSION 5 0.0062
8 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 4 0.0061
9 PRODUCT BLISTER PACKAGING ISSUE 5 0.0048
See all enriched reactions for CEDAZURIDINE AND DECITABINE